NCT05420948: A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 30 planned
- Started
- 17 Oct 2022
- Primary completion
- 1 Dec 2026
- Arms
- Group 1: Participants Who Receive Pembrolizumab (Alone)
- Results
- None posted
- 15 Jun 2022: Trial registered
- 17 Oct 2022: Trial started